A Study of MX006 in Patients With Advanced and/or Metastatic Tumors Known to Express B7-H3

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of MX006 in Patients With Advanced and/or Metastatic Tumors Known to Express B7-H3	Advanced and/or Metastatic Solid Tumors Known to Express B7-H3	Recruiting	Phase 1	2026-09-08		NCT07807241

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Myricx Pharma Limited	1

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Florida Cancer Specialists	Sarasota	United States	47
MD Anderson Cancer Center	Houston	United States	589
NEXT Oncology	San Antonio	United States	70
NEXT Oncology Virginia	Fairfax	United States	40

Clinical trials